Alcon (SIX/NYSE: ALC), the global eye care leader dedicated to helping people see with clarity, today announced the approval of the Clareon MD PanOptix MD Pro intraocular lens (IOL) for cataract patients in Canada. The PanOptix Pro IOL features ENLIGHTEN MD NXT optics , a proprietary…
In response to Harbour BioMed’s recent press release regarding a decision in its pending lawsuit, Biocytogen is issuing the following statement: Biocytogen operates in accordance with its core values: independent innovation, respect for intellectual property, and commitment to fair competition . The…
CharmHealth, a leader in healthcare technology solutions for providers, today announced that its 2025 Innovation Challenge continues to accept proposals from innovators, entrepreneurs and developers. The annual competition seeks fresh ideas that drive impact across the healthcare ecosystem. “The Innovation Challenge is…
A digital health leader revolutionizing AI-driven cardiometabolic care, today announced its selection by Modern Healthcare as one of the 2025 Best Places to Work in Healthcare. This national award recognizes top employers in the healthcare industry. The highly competitive selection process,…
Invivoscribe is pleased to announce that the NPM1 MRD Assay developed by its wholly owned subsidiary, the Laboratory for Personalized Molecular Medicine ® (LabPMM), has been approved by the State of New York. This approval comes just two months after the FLT3 ITD MRD Assay was approved…
The HRT Club, a leading pioneer of direct-to-consumer hormone replacement therapies, today announced a strategic partnership with Posterity Health, the leader in expert-led, comprehensive men’s health. Together, the two companies are creating a more robust and inclusive approach to hormonal health,…
Today released its fifth annual Healthcare Consumer Report, unveiling key insights into consumer sentiment about their health insurance plans. This year’s findings highlight the growing importance of affordability, transparency, member engagement, and the role of emerging technologies like artificial intelligence…
Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, announced the launch of its DIRECT-AI registry study. This study will assess how the ArteraAI Prostate Test influences treatment decision-making between clinicians and patients with localized prostate cancer. Additionally, the…
The nation’s leading tech-enabled hybrid care company, will unveil its state-of-the-art CareStation at Bradley International Airport in Connecticut. This landmark event marks the first deployment of an OnMed CareStation within an airport in the United States, a significant step towards…
Altera Digital Health Launches Sunrise 25.1 for Hospitals and Health Systems Altera Digital Health, a global health IT leader, today announced the general availability of Sunrise™ 25.1, the latest release of its complete electronic health record (EHR) system for mid-size hospitals…
MediStreams and Availity® Celebrate 10 Years of Innovation, Automating $61 Billion in Healthcare Revenue Cycle Payments MediStreams, a leader in revenue cycle remittance automation, and Availity, the nation’s largest dual-sided network with over 3 million providers on their platform and…
PACS Group to Restate Certain Previously Issued Financial Statements PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”) announced today that it will restate its previously issued condensed combined/consolidated financial statements as of and for the three months ended on…